Literature DB >> 31486048

Mathematical Modeling of Oncolytic Virotherapy.

Johannes P W Heidbuechel1,2, Daniel Abate-Daga3, Christine E Engeland1, Heiko Enderling4.   

Abstract

Mathematical modeling in biology has a long history as it allows the analysis and simulation of complex dynamic biological systems at little cost. A mathematical model trained on experimental or clinical data can be used to generate and evaluate hypotheses, to ask "what if" questions, and to perform in silico experiments to guide future experimentation and validation. Such models may help identify and provide insights into the mechanisms that drive changes in dynamic systems. While a mathematical model may never replace actual experiments, it can synergize with experiments to save time and resources by identifying experimental conditions that are unlikely to yield favorable outcomes, and by using optimization principles to identify experiments that are most likely to be successful. Over the past decade, numerous models have also been developed for oncolytic virotherapy, ranging from merely theoretic frameworks to fully integrated studies that utilize experimental data to generate actionable hypotheses. Here we describe how to develop such models for specific oncolytic virotherapy experimental setups, and which questions can and cannot be answered using integrated mathematical oncology.

Entities:  

Keywords:  Combination immunotherapy; Mathematical modeling; Oncology; Oncolytic virotherapy; Virus

Year:  2020        PMID: 31486048     DOI: 10.1007/978-1-4939-9794-7_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.

Authors:  Adrianne L Jenner; Munisha Smalley; David Goldman; William F Goins; Charles S Cobbs; Ralph B Puchalski; E Antonio Chiocca; Sean Lawler; Paul Macklin; Aaron Goldman; Morgan Craig
Journal:  iScience       Date:  2022-05-13

2.  Education and Outreach in Physical Sciences in Oncology.

Authors:  Sierra A Walker; Anthony Pham; Sara Nizzero; Mingee Kim; Bob Riter; Julie Bletz; Sheila Judge; Benette Phillips; Dorottya Noble; Diana Murray; Erin Wetzel; Susan Samson; Mariah McMahon; Carl Flink; Jennifer Couch; Claire Tomlin; Kristin Swanson; Alexander R A Anderson; David Odde; Haifa Shen; Shannon Hughes; Nastaran Zahir; Heiko Enderling; Joy Wolfram
Journal:  Trends Cancer       Date:  2020-11-07

Review 3.  Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.

Authors:  Johannes P W Heidbuechel; Christine E Engeland
Journal:  J Hematol Oncol       Date:  2021-04-16       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.